LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Primary central nervous system angiosarcoma with recurrent acute subdural hematoma.

    Valera-Melé, Marc / Darriba Allés, Juan Vicente / Ruiz Juretschke, Fernando / Sola Vendrell, Emma / Hernández Poveda, José Manuel / Montalvo Afonso, Antonio / Casitas Hernando, Vicente / García Leal, Roberto

    Neurocirugia (English Edition)

    2022  Volume 33, Issue 4, Page(s) 199–203

    Abstract: Angiosarcoma is an infrequent tumor among sarcomas, especially presenting as a primary tumor within the central nervous system, which can lead to a rapid neurological deterioration and death in few months. We present a 41-year old man with a right ... ...

    Abstract Angiosarcoma is an infrequent tumor among sarcomas, especially presenting as a primary tumor within the central nervous system, which can lead to a rapid neurological deterioration and death in few months. We present a 41-year old man with a right frontal enhancing hemorrhagic lesion. Surgery was performed with histopathological findings suggesting a primary central nervous system angiosarcoma. He was discharged uneventfully and received adjuvant chemotherapy and radiotherapy. At 5 months, the follow-up MRI showed two lesions with an acute subdural hematoma, suggesting a relapse. Surgery was again conducted finding tumoral membranes attached to the internal layer of the duramater around the right hemisphere. The patient died a few days later due to the recurrence of the subdural hematoma. This case report illustrates a rare and lethal complication of an unusual tumor. The literature reviewed shows that gross-total resection with adjuvant radiotherapy seems to be the best treatment of choice.
    MeSH term(s) Adult ; Central Nervous System ; Hemangiosarcoma/complications ; Hemangiosarcoma/diagnostic imaging ; Hemangiosarcoma/surgery ; Hematoma, Subdural, Acute/complications ; Hematoma, Subdural, Acute/etiology ; Humans ; Magnetic Resonance Imaging ; Male ; Neoplasm Recurrence, Local
    Language English
    Publishing date 2022-06-20
    Publishing country Spain
    Document type Case Reports
    ISSN 2529-8496
    ISSN (online) 2529-8496
    DOI 10.1016/j.neucie.2021.02.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Primary central nervous system angiosarcoma with recurrent acute subdural hematoma.

    Valera-Melé, Marc / Darriba Allés, Juan Vicente / Ruiz Juretschke, Fernando / Sola Vendrell, Emma / Hernández Poveda, José Manuel / Montalvo Afonso, Antonio / Casitas Hernando, Vicente / García Leal, Roberto

    Neurocirugia (English Edition)

    2021  

    Abstract: Angiosarcoma is an infrequent tumor among sarcomas, especially presenting as a primary tumor within the central nervous system, which can lead to a rapid neurological deterioration and death in few months. We present a 41-year old man with a right ... ...

    Abstract Angiosarcoma is an infrequent tumor among sarcomas, especially presenting as a primary tumor within the central nervous system, which can lead to a rapid neurological deterioration and death in few months. We present a 41-year old man with a right frontal enhancing hemorrhagic lesion. Surgery was performed with histopathological findings suggesting a primary central nervous system angiosarcoma. He was discharged uneventfully and received adjuvant chemotherapy and radiotherapy. At 5 months, the follow-up MRI showed two lesions with an acute subdural hematoma, suggesting a relapse. Surgery was again conducted finding tumoral membranes attached to the internal layer of the duramater around the right hemisphere. The patient died a few days later due to the recurrence of the subdural hematoma. This case report illustrates a rare and lethal complication of an unusual tumor. The literature reviewed shows that gross-total resection with adjuvant radiotherapy seems to be the best treatment of choice.
    Language Spanish
    Publishing date 2021-03-22
    Publishing country Spain
    Document type Case Reports
    ISSN 2529-8496
    ISSN (online) 2529-8496
    DOI 10.1016/j.neucir.2021.02.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: DREZotomy in the treatment of deafferentation pain: review of results and analysis of predictive factors for success.

    Montalvo Afonso, Antonio / Ruiz Juretschke, Fernando / González Rodrigálvarez, Rosario / Mateo Sierra, Olga / Iza Vallejo, Begoña / García Leal, Roberto / Valera Melé, Marc / Casitas Hernando, Vicente / Hernández Poveda, Jose Manuel / Fernández Carballal, Carlos

    Neurocirugia (English Edition)

    2020  Volume 32, Issue 1, Page(s) 1–9

    Abstract: Background and objectives: The treatment of deafferentation pain by spinal DREZotomy is a proven therapeutic option in the literature. In recent years, use of DREZotomy has been relegated to second place due to the emergence of neuromodulation therapies. ...

    Title translation Drezotomía en el tratamiento del dolor por desaferentización: revisión de resultados y análisis de factores predictores de éxito.
    Abstract Background and objectives: The treatment of deafferentation pain by spinal DREZotomy is a proven therapeutic option in the literature. In recent years, use of DREZotomy has been relegated to second place due to the emergence of neuromodulation therapies. The objectives of this study are to demonstrate that DREZotomy continues to be an effective and safe treatment and to analyse predictive factors for success.
    Patients and methods: A retrospective study was conducted of all patients treated in our department with spinal DREZotomy from 1998 to 2018. Bulbar DREZotomy procedures were excluded. A visual analogue scale (VAS) and the reduction of routine medication were used as outcome variables. Demographic, clinical and operative variables were analysed as predictive factors for success.
    Results: A total of 27 patients (51.9% female) with a mean age of 53.7 years underwent DREZotomy. The main cause of pain was brachial plexus injury (BPI) (55.6%) followed by neoplasms (18.5%). The mean time of pain evolution was 8.4 years with a mean intensity of 8.7 according to the VAS, even though 63% of the patients had previously received neurostimulation therapy. Favourable outcome (≥50% pain reduction in the VAS) was observed in 77.8% of patients during the postoperative period and remained in 59.3% of patients after 22 months average follow-up (mean reduction of 4.9 points). This allowed for a reduction in routine analgesic treatment in 70.4% of them. DREZotomy in BPI-related pain presented a significantly higher success rate (93%) than the other pathologies (41.7%) (p=.001). No association was observed between outcome and age, gender, DREZ technique, duration of pain or previous neurostimulation therapies. There were six neurological complications, four post-operative transient neurological deficits and two permanent deficits.
    Conclusion: Dorsal root entry zone surgery is effective and safe for treating patients with deafferentation pain, especially after brachial plexus injury. It can be considered an alternative treatment after failed neurostimulation techniques for pain control. However, its indication should be considered as the first therapeutic option after medical therapy failure due to its good long-term results.
    MeSH term(s) Brachial Plexus ; Brachial Plexus Neuropathies ; Causalgia/etiology ; Causalgia/therapy ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Spinal Nerve Roots/surgery
    Language Spanish
    Publishing date 2020-05-04
    Document type Journal Article ; Review
    ISSN 2529-8496
    ISSN (online) 2529-8496
    DOI 10.1016/j.neucir.2020.02.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top